This program is not affiliated with or endorsed by the ASRS
Thursday, July 16, 2025
5:15 PM – 5:30 PM EDT – Registration & Dinner
5:30 PM – 6:30 PM EDT – CE Symposium
Palais des congrès de Montréal
1001 Place Jean-Paul-Riopelle
Montréal, Quebec, H2Z 1H2
Métro Place-d’Armes
PROGRAM FEATURES
- Interactive, case-based learning environment
- Create your own personalized poster
PRESENTING FACULTY
 |
Eleonora Lad, MD, PhD Vice Chair of Clinical Research, Ophthalmology Professor of Ophthalmology Duke University Medical Center Durham, North Carolina |
 |
David S Chin Yee, MD, FASRS Physician Partner and Director of Clinical Trials Georgia Retina Stockbridge, Georgia |
PROGRAM OVERVIEW
This case-based symposium is designed to address the educational needs of retina specialists who care for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This expert-led presentation will examine the pathophysiology of GA, along with the role of the complement cascade, and practical use of advanced imaging techniques to support accurate diagnosis and ongoing monitoring. This program highlights the evolving therapeutic landscape, with a focus on clinical data and practical considerations for integrating recently approved and investigational therapies into patient-centered care. Participants will explore strategies for assessing disease progression, addressing patient-specific barriers, and optimizing disease management in collaboration with general ophthalmologists.
TARGET AUDIENCE
This program is designed to address the educational needs of retina specialists who care for patients with GA secondary to AMD.
LEARNING OBJECTIVES
- Summarize imaging modalities, clinical presentation of progressive GA, and the role of the complement cascade in disease pathogenesis
- Apply clinical data for the management of GA
- Develop strategies to monitor and comanage GA patients with ophthalmologists
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 ANCC contact hours.
COPE CREDIT DESIGNATION STATEMENT – Live
Med Learning Group designates this asynchronous activity for a maximum of 1.0 COPE credit hours.
ACCME INNOVATION PARTNER – US Learners Only
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
